Differences between ceftriaxone and cefotaxime: microbiological inconsistencies - Wikidata - wikimedia - TriplyDB

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

http://www.wikidata.org/entity/Q28261698

about

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

http://www.wikidata.org/entity/Q28261698

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@ast

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@en

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@nl

type

label

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@ast

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@en

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@nl

prefLabel

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@ast

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@en

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@nl

P1433

Q28261698-829141A4-C150-42D9-BFE0-D34DB4B77066

P1476

Q28261698-A847FA53-CC73-4E99-B468-86C0AC3E2BB5

P2093

Q28261698-25745037-BD36-425A-9F48-17678F5596CF

Q28261698-387EDCAB-1C9B-4175-AE3A-D86DF81E0403

Q28261698-789BAE15-520F-4CCB-93EB-7D9E75F25D1A

Q28261698-DC1F33C1-5147-4900-96A8-A086D7C1BA9B

Q28261698-E0C7376A-2F5E-4B2D-863C-0BCE40314C60

Q28261698-F2313E53-6B3D-4D27-AE67-0113DC331DC5

P2860

Q28261698-0366C47D-D1B6-4A8C-B320-8DA19C46EA95

Q28261698-03F73534-E865-4E54-8595-D50BD0E53D12

Q28261698-0894B29B-44F2-41EE-8A86-DE35C79BB7D1

Q28261698-0949206B-A8B8-442E-907C-AA728AEE749B

Q28261698-11893C0C-9ED8-4117-A09E-5154571DC708

Q28261698-3888C5AF-CFE7-4E14-A986-803107234282

Q28261698-6C785045-37E8-4D9E-9280-E6E18D97E640

Q28261698-CB185EAC-8974-4121-8E8A-111BFCB4F0FA

Q28261698-EFB3564D-1041-4CD7-81FF-28D9097AC811

Q28261698-FADB2B7A-20AB-426C-B51B-09CEE03DC347

P304

Q28261698-E394E0BA-B9A3-46A9-B13C-BCBD30E499DB

P31

Q28261698-C7B3895C-8316-4235-8272-DDDD3D8ED038

P356

Q28261698-45E6D46B-336C-42FE-8E13-0E0C85D53BEA

P407

Q28261698-CA77803F-500F-47F5-88C9-12346BFDD602

P433

Q28261698-5A981727-AD3C-410A-A02B-54E43C609BC3

P478

Q28261698-36E613D8-EB79-4118-A972-9B9BAB85F5DF

P577

Q28261698-2469C00B-B782-4E6F-A32B-C91D1190C298

P698

Q28261698-2DFEC563-FE8A-4A15-93C7-AAFBA31C47D5

P356

P1433

Annals of Pharmacotherapy

P1476

Differences between ceftriaxone and cefotaxime: microbiological inconsistencies

@en

P2093

D Wesston Boatwright

http://www.w3.org/2001/XMLSchema#string

Diane C Halstead

http://www.w3.org/2001/XMLSchema#string

John G Gums

http://www.w3.org/2001/XMLSchema#string

Mark Camblin

http://www.w3.org/2001/XMLSchema#string

Mark E Jones

http://www.w3.org/2001/XMLSchema#string

Roger Sanderson

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.

Analysis of penicillin-binding protein genes of clinical isolates of Streptococcus pneumoniae with reduced susceptibility to amoxicillin.

Reality of developing a community-wide antibiogram.

Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.

High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae.

Increasing ceftriaxone resistance and multiple alterations of penicillin-binding proteins among penicillin-resistant Streptococcus pneumoniae isolates in Taiwan.

In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.

P304

71-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1H620

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18094350

http://www.w3.org/2001/XMLSchema#string